NASDAQ : CRBU
Caribou Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.445 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 47.71M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Caribou Biosciences, Inc. (CRBU) reported revenue of 10.04M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 10.04M | 11.16M | 9.99M | 34.48M | 13.85M | 9.60M |
| Cost of Revenue | 83.85M | 107.52M | 130.15M | 112.08M | 82.23M | 52.26M |
| Gross Profit | -73.82M | -96.36M | -120.16M | -77.60M | -68.38M | -42.66M |
| Selling, General & Admin | 33.38M | 37.55M | 46.46M | 38.46M | 38.02M | 24.32M |
| Operating Expenses | 33.38M | 37.55M | 46.46M | 38.46M | 38.02M | 24.32M |
| Operating Income | -107.20M | -133.92M | -166.62M | -116.06M | -106.40M | -66.98M |
| Interest & Investment Income | 4.69M | 8.00M | 15.30M | 15.30M | ||
| Earnings From Equity Investments | -9.16M | |||||
| Other Non Operating Income (Expenses) | 827.00K | 827.00K | 2.20M | -1.12M | 7.18M | -1.21M |
| EBT Excluding Unusual Items | -101.68M | -134.25M | -149.11M | -101.88M | -99.22M | -68.19M |
| Merger & Restructuring Charges | -2.28M | -2.28M | ||||
| Gain (Loss) on Sale of Investments | -133.00K | |||||
| Asset Writedown | -12.15M | |||||
| Other Unusual Items | 1.58M | |||||
| Pretax Income | -103.95M | -148.68M | -149.11M | -101.88M | -99.35M | -66.60M |
| Income Tax Expense | -550.00K | -550.00K | -9.00K | 193.00K | 70.00K | 321.00K |
| Net Income | -103.40M | -148.12M | -149.10M | -102.07M | -99.42M | -66.92M |
| Net Income to Common | -103.40M | -148.12M | -149.10M | -102.07M | -99.42M | -66.92M |
| Shares Outstanding (Basic) | 96.18M | 93.39M | 90.32M | 73.81M | 60.80M | 31.66M |
| Shares Outstanding (Diluted) | 96.18M | 93.39M | 90.32M | 73.81M | 60.80M | 31.66M |
| EPS (Basic) | -1.08 | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 |
| EPS (Diluted) | -1.08 | -1.59 | -1.65 | -1.38 | -1.64 | -2.11 |
| Free Cash Flow | -95.75M | -112.35M | -143.08M | -104.90M | -97.42M | -34.64M |
| Free Cash Flow Per Share | -1.00 | -1.20 | -1.58 | -1.42 | -1.60 | -1.09 |
| Gross Margin | -225.07% | |||||
| Operating Margin | -1,068.22% | -1,200.09% | -1,667.16% | -336.63% | -768.17% | -697.84% |
| Profit Margin | -1,030.42% | -1,327.40% | -1,491.94% | -296.05% | -717.79% | -697.26% |
| Free Cash Flow Margin | -954.18% | -1,006.82% | -1,431.66% | -304.27% | -703.34% | -360.91% |
| EBITDA | -104.61M | -130.27M | -162.69M | -112.53M | -104.78M | -66.00M |
| D&A For EBITDA | 2.59M | 3.65M | 3.93M | 3.52M | 1.62M | 984.00K |
| EBIT | -107.20M | -133.92M | -166.62M | -116.06M | -106.40M | -66.98M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 26.19M | 12.36M | 16.29M | 51.16M | 58.34M | 240.42M |
| Short-Term Investments | 86.12M | 126.98M | 193.24M | 277.67M | 189.32M | 135.41M |
| Cash & Short-Term Investments | 112.31M | 139.34M | 209.54M | 328.83M | 247.66M | 375.83M |
| Accounts Receivable | 806.00K | 1.07M | 1.42M | 1.57M | 2.45M | 2.64M |
| Other Receivables | 1.14M | 1.90M | 1.83M | 2.29M | 2.21M | 5.48M |
| Receivables | 1.94M | 2.98M | 3.25M | 3.86M | 4.66M | 8.12M |
| Prepaid Expenses | 2.34M | 2.91M | 6.59M | 4.93M | 6.37M | 3.85M |
| Other Current Assets | 1.22M | 1.55M | 3.38M | |||
| Total Current Assets | 116.59M | 145.23M | 219.38M | 338.84M | 260.25M | 391.19M |
| Property, Plant & Equipment | 22.53M | 24.43M | 39.29M | 40.45M | 34.91M | 4.89M |
| Long-Term Investments | 1.50M | 3.50M | 49.12M | 51.33M | 77.07M | 45.30M |
| Other Long-Term Assets | 2.14M | 2.20M | 5.52M | 1.59M | 1.54M | 975.00K |
| Total Assets | 142.77M | 175.37M | 313.31M | 432.21M | 373.76M | 442.36M |
| Accounts Payable | 3.08M | 5.78M | 2.48M | 3.12M | 1.15M | 3.99M |
| Accrued Expenses | 11.45M | 15.72M | 21.94M | 19.65M | 14.41M | 12.09M |
| Current Portion of Leases | 1.38M | 1.20M | 1.43M | 1.20M | 966.00K | |
| Current Unearned Revenue | 372.00K | 1.90M | 3.13M | 2.85M | 9.94M | 8.70M |
| Other Current Liabilities | 1.70M | 816.00K | 1.68M | 1.48M | 1.67M | 1.05M |
| Total Current Liabilities | 17.97M | 25.41M | 30.65M | 28.30M | 28.13M | 25.83M |
| Long-Term Leases | 25.28M | 26.03M | 25.06M | 25.91M | 26.78M | |
| Long-Term Unearned Revenue | 1.42M | 1.75M | 3.32M | 6.10M | 15.95M | 22.03M |
| Long-Term Deferred Tax Liabilities | 548.00K | 557.00K | 381.00K | 476.00K | ||
| Other Long-Term Liabilities | 785.00K | 2.94M | 1.65M | 6.19M | ||
| Total Liabilities | 44.67M | 53.19M | 60.36M | 63.81M | 72.89M | 54.53M |
| Common Stock | 11.00K | 9.00K | 9.00K | 8.00K | 6.00K | 6.00K |
| Additional Paid-In Capital | 744.04M | 718.58M | 701.08M | 667.65M | 499.60M | 485.75M |
| Retained Earnings | -645.88M | -596.51M | -448.39M | -299.29M | -197.22M | -97.79M |
| Comprehensive Income & Other | -71.00K | 103.00K | 255.00K | 30.00K | -1.52M | -135.00K |
| Total Common Equity | 98.10M | 122.17M | 252.95M | 368.40M | 300.87M | 387.82M |
| Shareholders' Equity | 98.10M | 122.17M | 252.95M | 368.40M | 300.87M | 387.82M |
| Total Liabilities & Equity | 142.77M | 175.37M | 313.31M | 432.21M | 373.76M | 442.36M |
| Total Debt | 26.66M | 27.23M | 26.49M | 27.11M | 27.75M | |
| Net Cash (Debt) | 87.16M | 115.62M | 222.90M | 345.30M | 289.29M | 413.51M |
| Net Cash Per Share | 0.91 | 1.24 | 2.47 | 4.68 | 4.76 | 13.06 |
| Filing Date Shares Outstanding | 107.21M | 96.64M | 93.00M | 90.31M | 61.30M | 60.66M |
| Total Common Shares Outstanding | 106.00M | 95.14M | 92.38M | 88.45M | 61.03M | 60.26M |
| Working Capital | 98.62M | 119.82M | 188.73M | 310.54M | 232.12M | 365.36M |
| Book Value Per Share | 0.93 | 1.28 | 2.74 | 4.17 | 4.93 | 6.44 |
| Tangible Book Value | 98.10M | 122.17M | 252.95M | 368.40M | 300.87M | 387.82M |
| Tangible Book Value Per Share | 0.93 | 1.28 | 2.74 | 4.17 | 4.93 | 6.44 |
| Machinery | 17.24M | 17.23M | 20.65M | 16.98M | 13.46M | 7.25M |
| Construction In Progress | 8.20M | 993.00K | 9.00K | |||
| Leasehold Improvements | 3.06M | 3.06M | 11.52M | 2.23M | 1.88M | 1.70M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -103.40M | -148.12M | -149.10M | -102.07M | -99.42M | -66.92M |
| Depreciation & Amortization | 2.59M | 3.65M | 3.93M | 3.52M | 1.62M | 984.00K |
| Loss (Gain) From Sale of Assets | -25.00K | -9.00K | -34.00K | 4.00K | ||
| Asset Writedown & Restructuring Costs | 12.15M | 1.62M | 600.00K | 1.00M | ||
| Loss (Gain) From Sale of Investments | -605.00K | -1.04M | -4.62M | -4.42M | -664.00K | 52.00K |
| Loss (Gain) on Equity Investments | 9.16M | |||||
| Stock-Based Compensation | 10.50M | 12.68M | 16.71M | 13.75M | 11.72M | 3.45M |
| Other Operating Activities | 1.51M | 1.05M | -1.61M | 3.27M | -615.00K | -152.00K |
| Change in Accounts Receivable | 18.00K | 348.00K | 150.00K | 876.00K | 192.00K | -1.16M |
| Change in Accounts Payable | -163.00K | 3.25M | -354.00K | 1.82M | -2.72M | 1.14M |
| Change in Unearned Revenue | -2.81M | -2.80M | -2.50M | -16.94M | -4.84M | 29.64M |
| Change in Other Net Operating Assets | -2.88M | -740.00K | -2.40M | 6.75M | 3.26M | -867.00K |
| Operating Cash Flow | -95.78M | -110.99M | -138.20M | -93.29M | -90.97M | -32.52M |
| Capital Expenditures | 28.00K | -1.36M | -4.88M | -11.61M | -6.45M | -2.12M |
| Sale of Property, Plant & Equipment | 13.00K | |||||
| Sale (Purchase) of Intangibles | -1.62M | -600.00K | -1.00M | |||
| Investment in Securities | 71.72M | 103.60M | 93.10M | -56.57M | -86.19M | -173.28M |
| Investing Cash Flow | 71.75M | 102.24M | 86.61M | -68.18M | -93.25M | -176.40M |
| Long-Term Debt Issued | 1.15M | |||||
| Long-Term Debt Repaid | -119.00K | |||||
| Net Debt Issued (Repaid) | 1.03M | |||||
| Issuance of Common Stock | 24.98M | 4.82M | 16.72M | 154.30M | 2.13M | 323.57M |
| Financing Cash Flow | 24.98M | 4.82M | 16.72M | 154.30M | 2.13M | 433.43M |
| Net Cash Flow | 947.00K | -3.93M | -34.87M | -7.18M | -182.08M | 224.51M |
| Free Cash Flow | -95.75M | -112.35M | -143.08M | -104.90M | -97.42M | -34.64M |
| Free Cash Flow Margin | -954.18% | -1,006.82% | -1,431.66% | -304.27% | -703.34% | -360.91% |
| Free Cash Flow Per Share | -1.00 | -1.20 | -1.58 | -1.42 | -1.60 | -1.09 |
| Levered Free Cash Flow | -59.61M | -69.80M | -87.71M | -64.36M | -56.11M | -33.46M |
| Unlevered Free Cash Flow | -59.61M | -69.80M | -87.71M | -64.36M | -56.11M | -33.46M |
| Cash Income Tax Paid | 170.00K | 11.00K | ||||
| Change in Working Capital | -6.38M | -484.00K | -5.11M | -7.32M | -4.20M | 29.07M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 47.39M | 148.61M | 143.98M | 506.71M | 383.09M | 908.30M |
| Enterprise Value | -39.78M | 14.87M | -110.40M | 137.46M | 68.37M | 472.99M |
| Last Close Price | 0.42 | 1.59 | 1.59 | 5.73 | 6.28 | 15.09 |
| PS Ratio | 4.52 | 13.32 | 14.41 | 14.70 | 27.66 | 94.63 |
| PB Ratio | 0.46 | 1.22 | 0.57 | 1.38 | 1.27 | 2.34 |
| P/TBV Ratio | 0.46 | 1.22 | 0.57 | 1.38 | 1.27 | 2.34 |
| EV/Sales Ratio | 1.33 | 3.99 | 4.94 | 49.28 | ||
| Debt / Equity Ratio | 0.27 | 0.22 | 0.10 | 0.07 | 0.09 | |
| Net Debt / Equity Ratio | -0.89 | -0.95 | -0.88 | -0.94 | -0.96 | -1.07 |
| Net Debt / EBITDA Ratio | 0.83 | 0.89 | 1.37 | 3.07 | 2.76 | 6.27 |
| Net Debt / FCF Ratio | 0.91 | 1.03 | 1.56 | 3.29 | 2.97 | 11.94 |
| Asset Turnover | 0.06 | 0.05 | 0.03 | 0.09 | 0.03 | 0.04 |
| Quick Ratio | 6.36 | 5.60 | 6.94 | 11.76 | 8.97 | 14.87 |
| Current Ratio | 6.49 | 5.71 | 7.16 | 11.97 | 9.25 | 15.14 |
| Return on Equity (ROE) | -78.27% | -78.97% | -47.99% | -30.50% | -28.87% | -32.99% |
| Return on Assets (ROA) | -36.84% | -34.26% | -27.94% | -18.00% | -16.30% | -17.50% |
| Return on Capital Employed (ROCE) | -85.90% | -89.30% | -58.90% | -28.70% | -30.80% | -16.10% |
| Earnings Yield | -243.23% | -99.67% | -103.56% | -20.14% | -25.95% | -7.37% |
| FCF Yield | -211.05% | -75.60% | -99.38% | -20.70% | -25.43% | -3.81% |
| Buyback Yield / Dilution | -4.73% | -3.40% | -22.37% | -21.39% | -92.02% | -270.47% |